VERA Vera Therapeutics, Inc.
Healthcare$34.25+0.00%OpenMarket Cap: $2.46B
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
4.87
P/S
0.00
EV/EBITDA
-6.63
DCF Value
$4.05
FCF Yield
-12.0%
Div Yield
0.0%
Margins & Returns
Gross Margin
0.0%
Operating Margin
0.0%
Net Margin
0.0%
ROE
-74.9%
ROA
-59.3%
ROIC
-66.5%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $0.00 | -Infinity% | $-125.1M | $-121.0M | $— | — |
| Q4 null | $0.00 | Infinity% | $-94.2M | $-91.1M | $— | — |
| FY null | $0.00 | NaN% | $-315.5M | $-299.6M | $— | — |
| Q3 null | $0.00 | NaN% | $-83.9M | $-80.3M | $— | — |
| Q2 null | $0.00 | -Infinity% | $-80.1M | $-76.5M | $— | — |
| Q1 null | $0.00 | NaN% | $-57.2M | $-51.7M | $— | — |
| Q4 null | $0.00 | NaN% | $-48.9M | $-43.4M | $— | — |
| FY null | $0.00 | NaN% | $-167.2M | $-152.1M | $— | — |
| Q3 null | $0.00 | NaN% | $-49.8M | $-46.6M | $— | — |
| Q2 null | $0.00 | NaN% | $-37.3M | $-33.7M | $— | — |
| Q1 null | $0.00 | Infinity% | $-31.1M | $-28.4M | $— | — |
| Q4 2023 | $0.00 | Infinity% | $-27.0M | $-25.7M | $-0.58 | — |